OMEGA HEALTHCARE INVESTORS INC (OHI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 500M 1B 1.5B Q4 '17: 908.4M Q1 '18: 896.8M Q2 '18: 880.9M Q3 '18: 883.1M Q4 '18: 881.7M Q1 '19: 885.2M Q2 '19: 890.6M Q3 '19: 901.9M Q4 '19: 928.8M Q1 '20: 958.2M Q2 '20: 989.3M Q3 '20: 875.3M Q4 '20: 892.4M Q1 '21: 913.1M Q2 '21: 914.1M Q3 '21: 1.1B Q4 '21: 1.1B Q1 '22: 1B Q2 '22: 1B Q3 '22: 983.3M Q4 '22: 878.2M Q1 '23: 847.1M Q2 '23: 852.7M Q3 '23: 855.3M Q4 '23: 949.7M Q1 '24: 974.8M Q2 '24: 977.4M Q3 '24: 1B Q4 '24: 1.1B Q1 '25: 1.1B Q2 '25: 1.1B Q3 '25: 1.2B Q4 '25: 1.2B Q1 '26: 1.2B Q2 '26: 1.3B Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

0 250M 500M 750M Q4 '09: 115.9M Q1 '10: 121.7M Q2 '10: 126.7M Q3 '10: 132.7M Q2 '11: 132.2M Q3 '11: 138.6M Q4 '11: 137.8M Q1 '12: 174.5M Q2 '12: 187.5M Q1 '13: 228M Q2 '13: 241.1M Q3 '13: 251.3M Q4 '13: 265.7M Q1 '14: 284.2M Q2 '14: 299.3M Q2 '15: 342.7M Q2 '16: 489.8M Q3 '16: 488.1M Q4 '16: 560M Q1 '17: 602.6M Q2 '17: 601.5M Q3 '17: 388.9M Q4 '17: 315.2M Q1 '18: 314.1M Q2 '18: 305.7M Q3 '18: 504.6M Q4 '18: 497.6M Q1 '19: 481.6M Q2 '19: 475.5M Q3 '19: 552M Q4 '19: 551.7M Q1 '20: 577.3M Q2 '20: 607.3M Q3 '20: 380.7M Q3 '10 Q2 '12 Q1 '14 Q4 '16 Q1 '18 Q2 '19 Q3 '20

Net Income TTM

0 300M 600M 900M Q4 '09: 82.1M Q1 '10: 78.2M Q2 '10: 73.8M Q3 '10: 69.7M Q2 '11: 33.9M Q3 '11: 38.3M Q4 '11: 52.6M Q1 '12: 84.6M Q2 '12: 97.4M Q1 '13: 132.7M Q2 '13: 151.2M Q3 '13: 159.2M Q4 '13: 172.5M Q2 '15: 203.2M Q2 '16: 306.6M Q3 '16: 305.7M Q4 '16: 366.4M Q1 '17: 420M Q2 '17: 380.1M Q3 '17: 164M Q4 '17: 104.9M Q1 '18: 83.7M Q2 '18: 97.6M Q3 '18: 294.1M Q4 '18: 293.9M Q1 '19: 278.1M Q2 '19: 271.8M Q3 '19: 355.7M Q4 '19: 351.9M Q1 '20: 372M Q2 '20: 398.3M Q3 '20: 161.6M Q4 '20: 163.5M Q1 '21: 235.6M Q2 '21: 220.5M Q3 '21: 457.1M Q4 '21: 428.3M Q1 '22: 459.1M Q2 '22: 464.1M Q3 '22: 426.4M Q4 '22: 438.8M Q1 '23: 280.5M Q2 '23: 250.1M Q3 '23: 239M Q4 '23: 248.8M Q1 '24: 279.3M Q2 '24: 331.7M Q3 '24: 349.5M Q4 '24: 406.3M Q1 '25: 448M Q2 '25: 470.7M Q3 '25: 538.7M Q4 '25: 590.2M Q1 '26: 632.2M Q2 '26: 858.4M Q3 '11 Q4 '13 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

0 350M 700M 1.1B Q2 '10: 132.2M Q3 '10: 143.2M Q4 '10: 157.6M Q1 '11: 157.5M Q2 '11: 168.8M Q3 '11: 176.1M Q4 '11: 169.8M Q1 '12: 180.6M Q2 '12: 187M Q3 '12: 197.7M Q4 '12: 208.3M Q1 '13: 216.3M Q2 '13: 235.2M Q3 '13: 251.4M Q4 '13: 279.9M Q1 '14: 300.4M Q2 '14: 325.4M Q3 '14: 339.5M Q4 '14: 337.5M Q1 '15: 362.8M Q2 '15: 363.9M Q3 '15: 400.8M Q4 '15: 463.9M Q1 '16: 487.8M Q2 '16: 557.7M Q3 '16: 598.3M Q4 '16: 624.8M Q1 '17: 611.5M Q2 '17: 602.1M Q3 '17: 594.8M Q4 '17: 577.9M Q1 '18: 516.9M Q2 '18: 530.9M Q3 '18: 499.1M Q4 '18: 499.4M Q1 '19: 556.5M Q2 '19: 547.6M Q3 '19: 556.7M Q4 '19: 553.7M Q1 '20: 582.7M Q2 '20: 617.8M Q3 '20: 658.9M Q4 '20: 708.3M Q1 '21: 745.2M Q2 '21: 757.1M Q3 '21: 763M Q4 '21: 722.1M Q1 '22: 678.4M Q2 '22: 649M Q3 '22: 628.6M Q4 '22: 625.7M Q1 '23: 604.9M Q2 '23: 602.3M Q3 '23: 606.4M Q4 '23: 617.7M Q1 '24: 657.9M Q2 '24: 671.6M Q3 '24: 685.4M Q4 '24: 749.4M Q1 '25: 779.9M Q2 '25: 835.1M Q3 '25: 876.9M Q4 '25: 878.6M Q1 '26: 912.1M Q2 '26: 890.6M Q3 '10 Q4 '12 Q1 '15 Q2 '17 Q3 '19 Q4 '21 Q1 '24 Q2 '26

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 150M 300M 450M Q2 '09: 82.7M Q3 '09: 83.9M Q1 '10: 89M Q2 '10: 93.2M Q3 '10: 96M Q3 '10: 96M Q1 '11: 100.1M Q2 '11: 102M Q3 '11: 103.2M Q1 '12: 104M Q2 '12: 106M Q2 '12: 106M Q3 '12: 109.7M Q1 '13: 113.5M Q2 '13: 117M Q3 '13: 118.5M Q1 '14: 124.8M Q2 '14: 127.4M Q2 '14: 127.4M Q3 '14: 128.4M Q3 '14: 128.4M Q1 '15: 134.8M Q2 '15: 194.5K Q3 '15: 195.2K Q3 '15: 195.2M Q1 '16: 198.3M Q2 '16: 199.2M Q3 '16: 204.1M Q1 '17: 206.2M Q2 '17: 206.7M Q3 '17: 206.7M Q1 '18: 207.8M Q2 '18: 208.5M Q3 '18: 210.4M Q1 '19: 213.5M Q2 '19: 220.5M Q3 '19: 226.5M Q1 '20: 234.5M Q2 '20: 234.5M Q3 '20: 233.7M Q1 '21: 239.9M Q2 '21: 243.9M Q3 '21: 246.6M Q1 '22: 247.6M Q2 '22: 243.3M Q3 '22: 243.3M Q1 '23: 243.2M Q2 '23: 246.1M Q3 '23: 256M Q1 '24: 257.3M Q2 '24: 261.5M Q3 '24: 275.6M Q1 '25: 294.9M Q2 '25: 303.2M Q3 '25: 308.2M Q1 '26: 315.1M Q2 '26: 316.2M Q2 '09 Q3 '11 Q1 '14 Q3 '15 Q2 '18 Q1 '21 Q3 '23 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 1.00 2.00 3.00 Q4 '09: 0.87 Q1 '10: 0.80 Q2 '10: 0.73 Q3 '10: 0.66 Q2 '11: 0.24 Q3 '11: 0.30 Q4 '11: 0.46 Q1 '12: 0.82 Q2 '12: 0.94 Q1 '13: 1.20 Q2 '13: 1.33 Q3 '13: 1.38 Q4 '13: 1.46 Q2 '15: 1.45 Q3 '15: 1.40 Q4 '15: 1.28 Q1 '16: 1.25 Q2 '16: 1.61 Q3 '16: 1.58 Q4 '16: 1.89 Q1 '17: 2.13 Q2 '17: 1.89 Q3 '17: 0.82 Q4 '17: 0.50 Q1 '18: 0.39 Q2 '18: 0.45 Q3 '18: 1.40 Q4 '18: 1.40 Q1 '19: 1.32 Q2 '19: 1.27 Q3 '19: 1.62 Q4 '19: 1.58 Q1 '20: 1.63 Q2 '20: 1.72 Q3 '20: 0.69 Q4 '20: 0.70 Q1 '21: 1.00 Q2 '21: 0.93 Q3 '21: 1.91 Q4 '21: 1.76 Q1 '22: 1.86 Q2 '22: 1.88 Q3 '22: 1.73 Q4 '22: 1.80 Q1 '23: 1.16 Q2 '23: 1.03 Q3 '23: 0.97 Q4 '23: 0.99 Q1 '24: 1.11 Q2 '24: 1.31 Q3 '24: 1.36 Q4 '24: 1.55 Q1 '25: 1.61 Q2 '25: 1.62 Q3 '25: 1.79 Q4 '25: 1.93 Q1 '26: 2.07 Q2 '26: 2.80 Q1 '10 Q1 '13 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.